Boundless Bio Inc. (BOLD)
NASDAQ: BOLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BOLD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $60.05M
- EPS (TTM)
- -$2.85
- Dividend yield
- None
- 52-week range
- 0.961 – 3.16
- Day range
- 2.56 – 2.71
- Volume / Avg
- 116.89K / 179.14K
- Beta
- —
- Shares outstanding
- 22.75M
- Next earnings
- Nov 4, 2026
52-week range
BOLD stock today
On Oct 7, BOLD ended the session at $2.64, adding $0.07 (2.72%), versus the S&P 500's 0.22% decline. Shares are 16.6% below their 52-week high of $3.16, set on Aug 24, 2026 and 174.7% above the 52-week low of $0.961, in the middle of the past year's range. BOLD is up 120.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 114.6%.
Boundless Bio has posted a net loss over the last twelve months (EPS of -$2.85), so its P/E ratio is not meaningful. Boundless Bio's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Boundless Bio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- La Jolla, CA
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 4, 2026
BOLD news
All BOLD newsBoundless Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ATHEAlterity Therapeutics Limited ADR | 3.32 | -1.48% | $60.45M | vs BOLD |
| CNTBConnect Biopharma Holdings Limited | 0.9447 | +4.34% | $59.49M | vs BOLD |
| XLOXilio Therapeutics Inc. | 9.01 | +0.11% | $59.29M | vs BOLD |
| PLRXPliant Therapeutics Inc. | 0.99 | -3.88% | $61.30M | vs BOLD |
| RNXTRenovoRx Inc. | 1.37 | -1.44% | $61.83M | vs BOLD |
| ACETAdicet Bio Inc. | 6.18 | -1.12% | $57.85M | vs BOLD |
| GOSSGossamer Bio Inc. | 10.18 | -5.57% | $62.26M | vs BOLD |
| ALDXAldeyra Therapeutics Inc. | 0.9586 | +4.66% | $57.83M | vs BOLD |
Indexes, lists and sector
Boundless Bio stock FAQ
What is Boundless Bio's stock price today?
BOLD last traded at $2.64 as of Oct 7, 4:00 PM EDT, up 2.72% on the day. Prices are delayed at least 15 minutes.
When is Boundless Bio's next earnings date?
Boundless Bio is expected to report earnings on Wednesday, November 4, 2026.
What is the BOLD 52-week high?
The 52-week high for BOLD is $3.16 and the 52-week low is $0.961. The stock is currently 16.6% below its high.